Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/121103
Registo completo
Campo DCValorIdioma
dc.creatorHan, W-
dc.creatorAnderson, S-
dc.creatorMohiuddin, M-
dc.creatorBarros, D-
dc.creatorNakhai, S-
dc.creatorShin, E-
dc.creatorAmaral, IF-
dc.creatorPêgo, AP-
dc.creatorGarcía, A-
dc.creatorJang, Y-
dc.date.accessioned2019-07-15T09:48:36Z-
dc.date.available2019-07-15T09:48:36Z-
dc.date.issued2018-
dc.identifier.issn2375-2548-
dc.identifier.urihttps://hdl.handle.net/10216/121103-
dc.description.abstractMuscle satellite cells (MuSCs) play a central role in muscle regeneration, but their quantity and function decline with comorbidity of trauma, aging, and muscle diseases. Although transplantation of MuSCs in traumatically injured muscle in the comorbid context of aging or pathology is a strategy to boost muscle regeneration, an effective cell delivery strategy in these contexts has not been developed. We engineered a synthetic hydrogel-based matrix with optimal mechanical, cell-adhesive, and protease-degradable properties that promotes MuSC survival, proliferation, and differentiation. Furthermore, we establish a biomaterial-mediated cell delivery strategy for treating muscle trauma, where intramuscular injections may not be applicable. Delivery of MuSCs in the engineered matrix significantly improved in vivo cell survival, proliferation, and engraftment in nonirradiated and immunocompetent muscles of aged and dystrophic mice compared to collagen gels and cell-only controls. This platform may be suitable for treating craniofacial and limb muscle trauma, as well as postoperative wounds of elderly and dystrophic patients.-
dc.description.sponsorshipResearch reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH under award numbers R21AR072287 (to Y.C.J.) and R01AR062368 (to A.J.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also funded by the Parker H. Petit Institute for Bioengineering and Bioscience Seed Grant Program (to A.J.G. and Y.C.J.).-
dc.language.isoeng-
dc.publisherAmerican Association for the Advancement of Science-
dc.relation.ispartofScience Advances, vol.4(8):eaar4008-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.subject.meshCell-adhesives-
dc.subject.meshCo morbidities-
dc.subject.meshIntramuscular injections-
dc.subject.meshMuscle disease-
dc.subject.meshMuscle regeneration-
dc.subject.meshMuscle satellite cells-
dc.subject.meshSatellite cells-
dc.subject.meshSkeletal muscle-
dc.titleSynthetic matrix enhances transplanted satellite cell engraftment in dystrophic and aged skeletal muscle with comorbid trauma-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde-
dc.identifier.doi10.1126/sciadv.aar4008-
dc.relation.publisherversionhttps://advances.sciencemag.org/content/4/8/eaar4008-
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Han2018.pdf2.17 MBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons